Fig. 4From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancyAxial post-contrast CT, PET, and fused PET/CT images for a 50-year-old male patient with gastric antrum adenocarcinoma and had received chemotherapy. Images a–c showed an ill-defined gastric antrum metabolically active lesion (red arrows) merging with metabolically active omental soft tissue sheet (blue arrows) with SUVmax ~ 13.8. Images d–f showed multiple metabolically active peritoneal nodular lesions (blue arrows) with SUVmax ~ 17.8; moreover, a moderate to marked low grade metabolically active ascites (yellow arrows) was seenBack to article page